Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

 « Previous 10 Page of 30 Next 10 »

Investigational Therapy Could Attack Cause of Sickle Cell Crises

Treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might be able to interfere with the underlying cause of these events, known as vaso-occlusion crises, researchers at Duke Medicine report.

Guidelines Suggest Blood Thinners For More Women, Seniors

Nearly all women and people over 65 in the U.S. with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute.

Retinal Swelling in Premature Infants Tied to Poorer Neuro-Development

Using a portable, non-invasive imaging device, a team of Duke Medicine doctors have identified swelling in the back of the eyes of premature infants that correlates with poorer neurodevelopment as the babies grow.

Duke Awarded $10.4 Million Contract To Continue Developing Radiation Test

In the event of nuclear meltdown or improvised nuclear bomb, presumed victims of radiation exposure would overwhelm emergency responders and hospitals. Victims can’t smell or see radiation around them, and low-level exposure doesn’t result in obvious bodily injury. The likely outcome: long lines of patients with no visual symptoms, panicked and difficult to assess.

Gene Mutation Drives Cartilage Tumor Formation

Duke Medicine researchers have shown how gene mutations may cause common forms of cartilage tumors.

Newly Discovered Protein Has Link to Gestational Diabetes

For at least 40 years, scientists who study how the body metabolizes sugar have accepted one point: there are four enzymes that kick-start the body’s process of getting energy from food.

Duke’s Robert Califf Named as Deputy FDA Commissioner

Robert Califf, M.D., vice chancellor of clinical and translational research at Duke University School of Medicine and a global leader in cardiovascular medicine, clinical and translational research and medical economics, has been named deputy commissioner for Medical Products and Tobacco at the Food and Drug Administration.

High Cholesterol In 30s, 40s, Increases Later Risk Of Heart Disease

Most young adults might assume they have years before needing to worry about their cholesterol.

Human Mode Of Responding To HIV Vaccine Is Conserved From Monkeys

The antibody response from an HIV vaccine trial in Thailand was made possible by a genetic trait carried over in humans from an ancient ancestry with monkeys and apes, according to a study led by Duke Medicine researchers.

DCRI Awarded Federal Contract to Test New Anti-Infection Drugs

The Duke Clinical Research Institute will become one of three national sites to run early clinical trials of new anti-infection therapies under a contract announced by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

 « Previous 10 Page of 30 Next 10 »